Polo-like Kinase 1 (PLK1) Regulates Interferon (IFN) Induction by MAVS

作者: Damien Vitour , Stéphanie Dabo , Malek Ahmadi Pour , Myriam Vilasco , Pierre-Olivier Vidalain

DOI: 10.1074/JBC.M109.018275

关键词:

摘要: The mitochondria-bound adapter MAVS participates in IFN induction by recruitment of downstream partners such as members the TRAF family, leading to activation NF-κB, and IRF3 pathways. A yeast two-hybrid search for MAVS-interacting proteins yielded Polo-box domain (PBD) mitotic Polo-like kinase PLK1. We showed that PBD associates with two different domains both dependent independent phosphorylation events. phosphodependent association requires phosphopeptide binding ability PBD. It takes place proline-rich MAVS, within an STP motif, characteristic PLK1 its targets, where central Thr234 residue is phosphorylated. Its phosphoindependent at C terminus MAVS. strongly inhibits activate NF-κB pathways induce IFN. Reciprocally, depletion can increase response RIG-I/SeV or RIG-I/poly(I)-poly(C) treatments. This inhibition on it disrupts partner TRAF3. was inhibited cells arrested G2/M nocodazole, which provokes increased expression endogenous Interestingly, from these nocodazole-treated could restore, least partially, induction. Altogether, data demonstrate a new function regulator provide basis development inhibitors preventing PLK1/MAVS sustain innate immunity.

参考文章(57)
Mary E. McManaway, Susan E. Bates, Marc E. Lippman, Robert B. Dickson, Characterization of estrogen responsive transforming activity in human breast cancer cell lines Cancer Research. ,vol. 46, pp. 1707- 1713 ,(1986)
D.-c. Kang, R. V. Gopalkrishnan, Q. Wu, E. Jankowsky, A. M. Pyle, P. B. Fisher, mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 637- 642 ,(2002) , 10.1073/PNAS.022637199
Rüdiger Neef, Ulrike Gruneberg, Robert Kopajtich, Xiuling Li, Erich A. Nigg, Herman Sillje, Francis A. Barr, Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1 Nature Cell Biology. ,vol. 9, pp. 436- 444 ,(2007) , 10.1038/NCB1557
Chris B. Moore, Daniel T. Bergstralh, Joseph A. Duncan, Yu Lei, Thomas E. Morrison, Albert G. Zimmermann, Mary A. Accavitti-Loper, Victoria J. Madden, Lijun Sun, Zhengmao Ye, John D. Lich, Mark T. Heise, Zhijian Chen, Jenny P-Y. Ting, NLRX1 is a regulator of mitochondrial antiviral immunity Nature. ,vol. 451, pp. 573- 577 ,(2008) , 10.1038/NATURE06501
Klaus Strebhardt, Axel Ullrich, Targeting polo-like kinase 1 for cancer therapy Nature Reviews Cancer. ,vol. 6, pp. 321- 330 ,(2006) , 10.1038/NRC1841
Kiranmai Gumireddy, M.V. Ramana Reddy, Stephen C. Cosenza, R. Boomi Nathan, Stacey J. Baker, Nabisa Papathi, Jiandong Jiang, James Holland, E. Premkumar Reddy, ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent Cancer Cell. ,vol. 7, pp. 275- 286 ,(2005) , 10.1016/J.CCR.2005.02.009
Tiejun Zhao, Long Yang, Qiang Sun, Meztli Arguello, Dean W Ballard, John Hiscott, Rongtuan Lin, The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nature Immunology. ,vol. 8, pp. 592- 600 ,(2007) , 10.1038/NI1465
Laura Strahle, Dominique Garcin, Daniel Kolakofsky, Sendai virus defective-interfering genomes and the activation of interferon-beta Virology. ,vol. 351, pp. 101- 111 ,(2006) , 10.1016/J.VIROL.2006.03.022
Andrew EH Elia, Lewis C Cantley, Michael B Yaffe, Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates Science. ,vol. 299, pp. 1228- 1231 ,(2003) , 10.1126/SCIENCE.1079079
Micheline Fromont-Racine, Jean-Christophe Rain, Pierre Legrain, Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens Nature Genetics. ,vol. 16, pp. 277- 282 ,(1997) , 10.1038/NG0797-277